substance p has been researched along with Gigantism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davoodi, J; Gendron, NH; Kelly, J; MacKenzie, AE | 1 |
| Abe, H; Chihara, K; Daigo, S; Iwasaki, Y; Kato, Y | 1 |
1 review(s) available for substance p and Gigantism
| Article | Year |
|---|---|
[Regulation of growth hormone secretion].
Topics: Animals; Autonomic Agents; gamma-Aminobutyric Acid; Gigantism; Growth Hormone; Humans; Hypophysectomy; Hypothalamus; Male; Rats; Somatostatin; Substance P; Thyrotropin-Releasing Hormone | 1977 |
1 other study(ies) available for substance p and Gigantism
| Article | Year |
|---|---|
The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26.
Topics: Abnormalities, Multiple; Adenosine Deaminase; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; Chromatography, Affinity; COS Cells; Dipeptidyl Peptidase 4; Electrophoresis, Polyacrylamide Gel; Genetic Diseases, X-Linked; Gigantism; Glycoproteins; Glypicans; Humans; Protein Binding; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substance P; Syndrome; Transfection | 2007 |